Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma
1 विचारों
administrator
08/09/23
Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली